FDA may ditch some TV ad requirements

Share this article:

The FDA is rethinking just how many side effects need to be talked about in television ads.

The LA Times reports that the regulator is surveying 1,500 participants to see just how much information they take in and understand when watching advertisements.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Panel votes against painkiller

Panel chair Randall Flick said QRxPharma "had not provided sufficient evidence to support a claim that Moxduo is safer than morphine or oxycodone."

Amgen sales rose by 5% in Q1

But demand for Enbrel and Aranesp slipped.

FDA reviews new painkiller

The candidate would be the first to put oxycodone and morphine in one capsule.